Health & bio

Novo Nordisk Wegovy Oral Formulation Enters GLP-1 Pill Market

Novo Nordisk's Wegovy oral formulation gained market entry, with a starting dose of 1.5mg available at $149 monthly through pharmacies and telehealth channels.

Primary sources · 1

CNBC

← View the full 2026-04-23 (Wed) issue

What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →